NCT01940198已完成不适用
Long-term Atazanavir Experience in a High HIV Caseload Primary Care Practice in Sydney, Australia
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 117
- 试验地点
- 1
- 主要终点
- Proportion of HIV-1 infected participants with atazanavir experience
研究概览
简要总结
This observational study will aim to determine long-term atazanavir experience in a high HIV caseload primary care practice in Sydney, Australia.
详细描述
This observational study will aim to determine long term atazanavir experience in HIV-1 infected patients in a primary care setting.
- OBJECTIVES OF THE STUDY i. Primary objective Long-term (2 years or greater) atazanavir experience in HIV-1 infected patients in a primary care setting through retrospective data collection.
ii. Secondary objectives
- To illustrate long term therapeutic efficacy of atazanavir in ART naïve and experienced HIV-1 infected patients.
- To illustrate long term tolerability to atazanavir in ART naïve and experienced HIV-1 infected patients.
- To identify ART treatment history in ART naïve and experienced HIV-1 infected patients on ATV.
- To identify contraindicated therapy in ART naïve and experienced HIV-1 infected patients on ATV.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •HIV-1 positive
- •Have commenced ATV between 2002-2008 (Baseline)
- •Follow-up data (clinical and laboratory) available from baseline
排除标准
- •Patients not commenced ATV between 2002-2008
- •No follow-up data (clinical and laboratory) available from baseline
- •Patient 'lost to follow-up' with < 2 years of follow-up data (Clinical and laboratory)
结局指标
主要结局
Proportion of HIV-1 infected participants with atazanavir experience
时间窗: 1 year
Proportion of patients who continue on atazanavir for 2 years or greater from baseline to termination/current.
次要结局
- Proportion of HIV-1 infected participants with atazanavir experience(1 year)
研究者
Dr. Mark Bloch
Principal Investigator
Holdsworth House Medical Practice
研究点 (1)
Loading locations...
相似试验
已完成
不适用
IMPAACT P1074: Long-Term Outcomes in HIV-Infected Infants, Children, and AdolescentsHIV InfectionsNCT01061164International Maternal Pediatric Adolescent AIDS Clinical Trials Group1,207
招募中
不适用
A Long-term Follow-up of the HIV-NAT CohortHIV InfectionsNCT00411983The HIV Netherlands Australia Thailand Research Collaboration10,000
已完成
不适用
Long-term Study in Patients Under Anti-retroviral Combination Therapy Switching to Viramune®HIV InfectionsNCT02191293Boehringer Ingelheim228
终止
2 期
Pharmacokinetics of Atazanavir /Dolutegravir/Lamivudine Regimen as Maintenance RegimenHIV-1 InfectionNCT02566707Radboud University Medical Center9
已完成
2 期
Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and TruvadaHIV InfectionsNCT00528060French National Agency for Research on AIDS and Viral Hepatitis35